Provided by Tiger Trade Technology Pte. Ltd.

Meiragtx Holdings Plc

8.09
+0.47006.17%
Pre-market: 8.110.0200+0.25%07:50 EDT
Volume:1.39M
Turnover:10.95M
Market Cap:656.27M
PE:-5.70
High:8.10
Open:7.40
Low:7.01
Close:7.62
52wk High:9.73
52wk Low:4.55
Shares:81.12M
Float Shares:31.70M
Volume Ratio:2.35
T/O Rate:4.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4199
EPS(LYR):-1.4199
ROE:-368.19%
ROA:-25.76%
PB:-113.29
PE(LYR):-5.70

Loading ...

REFILE-BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Tower Semiconductor, GlobalFoundries

Reuters
·
Nov 11, 2025

Eli Lilly Stock Rises 5% to Record High. It Signs Deal for MeiraGTx's Gene Therapy for Severe Eye Disease

Reuters
·
Nov 10, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Instacart, Plug Power, Crypto stocks

Reuters
·
Nov 10, 2025

Shares of MeiraGTx Holdings Rise 11.5% on Collaboration With Eli Lilly for Rare Eye Disease Treatment

THOMSON REUTERS
·
Nov 10, 2025

MeiraGTx Showcases Advancements in Genetic Medicine with Late-Stage Clinical Pipeline and Manufacturing Capabilities

Reuters
·
Nov 10, 2025

MeiraGTx Announces Strategic Collaboration with Eli Lilly for Ophthalmology Gene Therapies

Reuters
·
Nov 10, 2025

MeiraGTx Enters Into Strategic Collaboration With Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology

THOMSON REUTERS
·
Nov 10, 2025

MeiraGTx Holdings Plc - to Receive $75 Mln Upfront and $400 Mln in Milestones

THOMSON REUTERS
·
Nov 10, 2025

MeiraGTx Holdings Plc - Grants Lilly Exclusive Rights to Aav-Aipl1 Program

THOMSON REUTERS
·
Nov 10, 2025

MeiraGTx Holdings PLC expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

MeiraGTx Holdings (NASDAQ:MGTX) Is Making Moderate Use Of Debt

Simply Wall St.
·
Oct 22, 2025

MeiraGTx CFO & COO Richard Giroux Reports Disposal of Common Shares

Reuters
·
Oct 22, 2025

MeiraGTx initiated with a Strong Buy at Raymond James

TIPRANKS
·
Oct 21, 2025

MeiraGTx Holdings plc President & CEO Alexandria Forbes Reports Disposal of Common Shares

Reuters
·
Oct 08, 2025

BRIEF-MeiraGTx Announces Two Posters At The European Society Of Gene And Cell Therapy (ESGCT) 2025 Annual Congress

Reuters
·
Oct 07, 2025

MeiraGTx Announces Promising New Clinical Study on Novel AAV Gene Therapy Capsids for Ocular Diseases at ESGCT 2025

Reuters
·
Oct 07, 2025

MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (Esgct) 2025 Annual Congress

THOMSON REUTERS
·
Oct 07, 2025

Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations to Drive Next Phase of Growth

Reuters
·
Oct 02, 2025